Citigroup Inc Emergent Bio Solutions Inc. Transaction History
Citigroup Inc
- $190 Billion
- Q1 2025
A detailed history of Citigroup Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Citigroup Inc holds 87,184 shares of EBS stock, worth $565,824. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87,184
Previous 85,519
1.95%
Holding current value
$565,824
Previous $817,000
48.23%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding EBS
# of Institutions
177Shares Held
38.3MCall Options Held
94.1KPut Options Held
153K-
Black Rock Inc. New York, NY3.84MShares$24.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$20.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.5MShares$16.2 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO2.3MShares$14.9 Million0.01% of portfolio
-
State Street Corp Boston, MA1.71MShares$11.1 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $324M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...